Qingdao Haier BiomedicalLtd (SHSE:688139) earnings and shareholder returns have been trending downwards for the last three years, but the stock climbs 7.2% this past week

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But the last three years have been particularly tough on longer term Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) shareholders. So they might be feeling emotional about the 52% share price collapse, in that time. Contrary to the longer term story, the last month has been good for stockholders, with a share price gain of 8.4%. But this could be related to good market conditions, with stocks up around 4.8% during the period.

The recent uptick of 7.2% could be a positive sign of things to come, so let's take a look at historical fundamentals.

View our latest analysis for Qingdao Haier BiomedicalLtd

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

During the three years that the share price fell, Qingdao Haier BiomedicalLtd's earnings per share (EPS) dropped by 24% each year. This change in EPS is reasonably close to the 21% average annual decrease in the share price. That suggests that the market sentiment around the company hasn't changed much over that time, despite the disappointment. It seems like the share price is reflecting the declining earnings per share.

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

A Different Perspective

Qingdao Haier BiomedicalLtd shareholders gained a total return of 9.0% during the year. But that was short of the market average. On the bright side, that's still a gain, and it is certainly better than the yearly loss of about 0.9% endured over half a decade. So this might be a sign the business has turned its fortunes around. It's always interesting to track share price performance over the longer term. But to understand Qingdao Haier BiomedicalLtd better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Qingdao Haier BiomedicalLtd , and understanding them should be part of your investment process.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.